EP2818184
Samsetningar og aðferðir til að meðhöndla purpura
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
17.11.2008EP published:
31.10.2018EP application number:
14170999.8
EP translation filed:
19.2.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
16.11.2028Expiry date:
16.11.2024
Title:
Compositions and methods for treating Purpura
Timeline
Today
17.11.2008EP application
31.10.2018EP Publication
19.2.2019Translation submitted
15.3.2019Registration published
16.11.2024Expires
Owner
Name:
Aclaris Therapeutics, Inc.Address:
640 Lee Road, Suite 200, 19087, Wayne, PA, US
Inventor
Name:
Shanler, Stuart D.Address:
Pamona, NY New York, US
Name:
Ondo, AndrewAddress:
Las Cruces, NM New Mexico, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
988564 PDate:
16.11.2007Country:
US
Classification
Categories:
A61K 45/06, A61P 17/00, A61K 31/498, A61K 31/4174, A61K 31/137
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 2.1.2019
Expires: 16.11.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 12
Paid: 31.10.2019
Expires: 16.11.2020
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 2.11.2020
Expires: 16.11.2021
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 2.11.2021
Expires: 16.11.2022
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 1.11.2022
Expires: 16.11.2023
Payer: Patice ehf.
Number: 16
Paid: 31.10.2023
Expires: 16.11.2024
Payer: Árnason Faktor ehf.